Lyell Prices $80M Private Placement at $10.77/Share, 7.43M Shares
LYEL sits 63% above its 52-week low of $7.195.
Summary
Lyell is raising about $80 million by selling 7.43 million shares at $10.77 each in a private placement, with closing expected around November 4, 2026. The proceeds fund the ronde-cel CAR-T program, at the cost of dilution and a resale registration obligation within 30 days.
Key Events · Financing and Capital Events · LYEL
-
Private Placement Priced at $10.77
Lyell agreed to sell 7,428,040 shares at $10.77 per share to institutional accredited investors under a Securities Purchase Agreement dated November 3, 2026.
-
Gross Proceeds of ~$80 Million
7,428,040 shares x $10.77 = ~$80.0 million before expenses, matching the company's stated expected gross proceeds.
-
Resale Registration Deadline
Lyell must file a resale registration statement within 30 days of closing and faces cash penalties if registration fails or is delayed.
-
Closing Expected November 4, 2026
The private placement is subject to customary closing conditions and is scheduled to close on or about November 4, 2026.
Analysis · LYEL · Life Sciences
Lyell locked in roughly $80 million of gross proceeds by selling 7,428,040 new shares at $10.77 apiece to institutional accredited investors — a price below today's $11.76 quote, so the buyers got a discount to the current market. The cash extends the runway for the ronde-cel CAR-T program, but existing holders absorb real dilution from the newly issued stock. The company also committed to registering the shares for resale within 30 days of closing and faces cash penalties if that registration slips, which puts a tradable overhang on the stock shortly after the deal closes.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LYEL was trading at $11.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $263.9M. The 52-week trading range was $7.20 to $45.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.